个性化文献订阅>期刊> Blood
 

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

  作者 Pallasch, CP; Patz, M; Park, YJ; Hagist, S; Eggle, D; Claus, R; Debey-Pascher, S; Schulz, A; Frenzel, LP; Claasen, J; Kutsch, N; Krause, G; Mayr, C; Rosenwald, A; Plass, C; Schultze, JL; Hallek, M; Wendtner, CM  
  选自 期刊  Blood;  卷期  2009年114-15;  页码  3255-3264  
  关联知识点  
 

[摘要]MicroRNAs (miRNA) play a key role in cellular regulation and, if deregulated, in the development of neoplastic disorders including chronic lymphocytic leukemia (CLL). RNAs from primary cells of 50 treatment-naive CLL patients and peripheral B cells of 14 healthy donors were applied to miRNA expression profiling using bead chip technology. In CLL cells, a set of 7 up-and 19 down-regulated miRNAs was identified. Among the miRNAs down-regulated in CLL cells, 6 of 10 miRNA promoters examined showed gain of methylation compared with normal B-cell controls. Subsequent target prediction of deregulated miRNAs revealed a highly significant binding prediction at the 3' untranslated region of the pleomorphic adenoma gene 1 (PLAG1) oncogene. Luciferase reporter assays including site-directed mutagenesis of binding sites revealed a significant regulation of PLAG1 by miR-181a, miR-181b, miR-107, and miR-424. Although expression of PLAG1 mRNA was not affected, PLAG1 protein expression was shown to be significantly elevated in CLL cells compared with the levels in healthy donor B cells. In summary, we could demonstrate disruption of miRNA-mediated translational control, partly due to epigenetic transcriptional silencing of miRNAs, with subsequent overexpression of the oncogenic transcription factor PLAG1 as a putative novel mechanism of CLL pathogenesis. (Blood. 2009; 114: 3255-3264)

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内